AstraZeneca’s Mene Pangalos awarded knighthood in the New Year 2020 Honours List

Mene Pangalos, Executive Vice President of BioPharmaceuticals Research and Development, has been awarded a knighthood by Her Majesty The Queen in the New Year 2020 Honours List in recognition of his services to UK science.

Based in Cambridge, Mene has overall responsibility for AstraZeneca’s research and development (R&D) activities in BioPharmaceuticals. Since joining in 2010, he has pioneered programmes to promote novel Open Innovation partnerships with non-governmental and peer organisations, and more than 200 academic institutions to help drive the UK’s position as a world leader in life sciences R&D.

Mene has also been the driving force behind an almost five-fold improvement in R&D productivity at AstraZeneca, measured by the number of pipeline molecules advancing from preclinical investigation to completion of Phase III clinical trials.
 

CEO Pascal Soriot interviews Sir Mene Pangalos:

Professor Dame Nancy Rothwell, President and Vice-Chancellor of the University of Manchester, UK, said “Mene has long been a champion of promoting and strengthening UK science through uniquely open ways of working between industry, academic, non-governmental and peer organisations. I am immensely proud to have worked alongside Mene across a number of collaborations to advance our understanding of complex disease and translate this into human benefit. Congratulations Sir Mene!”

Mene has made outstanding contributions throughout his career to UK science. He is a Fellow of the Academy of Medical Sciences, the Royal Society of Biology and Clare Hall, University of Cambridge. He sits on the Medical Research Council, co-chairs the Life Sciences Council Expert Group on Innovation, Clinical Research and Data, and is a member of the UK Life Sciences Industrial Strategy Implementation Board. He sits on the boards of The Francis Crick Institute, Cambridge University’s Judge Business School and Dizal Pharma, and is a member of the Royal Society's Science, Industry and Translation Committee.

Mene has held Visiting Professorships at King’s College London and the University of Pennsylvania and is the holder of honorary degrees from Glasgow University and Imperial College London. In 2019, Mene received the Greek Prix Galien Scientific Researcher Award.

About AstraZeneca

AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal and Metabolism, and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.

Contacts